Programme Thesis
The Qatar Development Bank Pre-Accelerator Program 2026 funds early-stage startups globally (with a MENA focus) that have an MVP and are ready to validate demand and build traction. It exists to help founders prepare for investment, offering mentorship, market-readiness support, and a potential $75K investment for 6% equity, while also supporting Qatar's startup ecosystem.
Selection Criteria
- Early-stage startup with an MVP or early product
- Incorporated startup (angel or pre-seed stage)
- Currently raising or preparing to raise investment
- Based in Africa, Asia, Europe, Middle East, North America, or South America
- Target sectors: B2B SaaS, AI, fintech-related enterprise tools, supply chain, logistics, agritech, edtech, proptech, advanced manufacturing, digital transformation
- Ability to benefit from mentorship and market-readiness support
- Potential to pitch successfully for up to $75K in exchange for 6% equity
- Commitment to program schedule (Oct 5 – Nov 25, 2026) including online sessions and in-person engagement in Doha
Past Winners / Cohort Profiles
The page does not list specific past winners, but the program targets early-stage startups with an MVP across various sectors, with a preference for tech-enabled ventures. Typical cohorts likely include founders from MENA and global regions, with a mix of B2B SaaS, AI, and fintech startups. The program funds 10 companies per year, suggesting a selective but not ultra-competitive cohort.
Ideal Candidate Fingerprint
The ideal applicant is an incorporated, pre-seed startup with a working MVP, a clear plan to validate demand and build traction, and a strong pitch for investment. They should be in a target sector (especially AI or B2B SaaS), be ready to engage with mentors and investors, and be open to the program's structure, including in-person sessions in Doha.
Recommended Framing
For Eniola Olutogun, the strongest angle is to position the venture as an AI-driven B2B SaaS platform for drug discovery, targeting the 'AI' and 'B2B SaaS' sectors explicitly. Emphasize the validated proof-of-concept (AUROC 0.804) and the clear roadmap to commercial traction (Servier pilot), which aligns with the program's focus on startups ready to validate demand and build traction. The venture's global applicability and potential for pharma partnerships fit the program's international scope, despite the MENA focus.
Watch Out
The venture is not yet incorporated, but the program requires incorporated startups. The program's target sectors do not explicitly include biotech or health-tech, though AI and B2B SaaS are listed, so the venture must be framed as an AI/B2B SaaS company. The program's MENA focus may limit networking and mentorship relevance for a Nigeria-based founder, though the program is open to Africa. The equity requirement (6% for $75K) may be a consideration for a pre-seed founder.
Research History
2026-08-04 20:01 · medium confidence
2026-07-30 09:09 · medium confidence